Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Daiichi Sankyo
Mayo Clinic
Institut Bergonié
Day One Biopharmaceuticals, Inc.
Memorial Sloan Kettering Cancer Center
Jules Bordet Institute
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)